Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

HealthLynked (HLYK) Return on Sales (2016 - 2025)

HealthLynked (HLYK) has disclosed Return on Sales for 10 consecutive years, with 1.36% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Sales rose 147.0% to 1.36% in Q3 2025 year-over-year; TTM through Sep 2025 was 1.18%, a 0.0% change, with the full-year FY2024 number at 2.04%, down 249.0% from a year prior.
  • Return on Sales was 1.36% for Q3 2025 at HealthLynked, down from 0.74% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 1.5% in Q1 2023 to a low of 5.17% in Q1 2021.
  • A 5-year average of 0.79% and a median of 0.34% in 2021 define the central range for Return on Sales.
  • Biggest YoY gain for Return on Sales was 1050bps in 2021; the steepest drop was -473bps in 2021.
  • HealthLynked's Return on Sales stood at 1.13% in 2021, then crashed by -259bps to 1.79% in 2022, then surged by 100bps to 0.0% in 2023, then plummeted by -7118827bps to 1.99% in 2024, then skyrocketed by 31bps to 1.36% in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Return on Sales are 1.36% (Q3 2025), 0.74% (Q2 2025), and 0.8% (Q1 2025).